Genetics of Osteoporosis: Half-Full or Half-Empty?
- José A. Riancho
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Osteoporosis is a common disorder in postmenopausal women and elderly men. Consequently, it is prevalent in developed countries with a long life expectancy. Bone fragility, related to low bone mass and other factors impairing bone quality, is the hallmark of osteoporosis and the cause of fractures, which represent its relevant consequence from a clinical point of view. The increased proportion of elderly subjects is expected to be associated with increasing rates of osteoporotic fractures, the so-called osteoporosis silent epidemics. However, several developments have brought some optimism onto this prediction.
During the last decade, new drugs have been developed which not only increase bone mineral density but also, most importantly, have been shown to reduce the risk of osteoporotic fractures by 30–70%. They include both anti-resorptive drugs (such as bisphosphonates, selective modulators of estrogen receptors and strontium ranelate) and anabolic drugs, particularly PTH. The identifi
- Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–65. CrossRef
- Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809–22. CrossRef
- Lesli WD, O’Donnell S, Jean S, Lagacé C, Walsh P, Bancej C, et al. Trends in hip fracture rates in Canada. JAMA. 2009;26:883–9. CrossRef
- Genetics of Osteoporosis: Half-Full or Half-Empty?
Clinical Reviews in Bone and Mineral Metabolism
Volume 8, Issue 2 , pp 49-50
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- Industry Sectors
- José A. Riancho (1)
- Author Affiliations
- 1. Department of Internal Medicine, Hospital U.M. Valdecilla-IFIMAV-RETICEF, University of Cantabria, Santander, Spain